Author

BD Smith

Observed names: B D Smith, Benjamin D. Smith

Institution: The University of Texas MD Anderson Cancer Center

Observed institutions: The University of Texas MD Anderson Cancer Center, Orlando Health, Banner Health, Deciphera Pharmaceuticals (United States)

ORCID: 0000-0001-7866-1093

Observed ORCID: 0000-0001-7866-1093

OpenAlex ID: A5104038751

Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial

2026 · Alexander D. Sherry, Cara Haymaker, et al. · Journal of Clinical Oncology · 7

Primary transitional cell carcinoma of the prostate: report of two cases.

1983 · B D Smith, G Flegel · PubMed · 1

Abstract P2-11-02: Three-year outcomes with hypofractionated (HF) versus conventionally fractionated (CF) whole breast irradiation (WBI)

2018 · SF Shaitelman, X Lei, et al. · Cancer Research

Abstract P4-15-13: Rebastinib in combination with paclitaxel ablates TIE2-expressing macrophages, reduces metastasis, and increases survival in the PyMT metastatic breast cancer model

2013 · BD Smith, CB Leary, et al. · Cancer Research

Works count: 4

Citation count: 8

H-index: 1

I10-index: